Catecholamine metabolites in human plasma as indices of brain function: Effects of debrisoquin
- 16 November 1980
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 27 (20) , 1857-1862
- https://doi.org/10.1016/0024-3205(80)90430-0
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Differential effects on brain catecholamines by debrisoquinBiochemical Pharmacology, 1979
- 3-Methoxy-4-Hydroxyphenethyleneglycol Production by Human Brain in VivoScience, 1979
- A DIRECT METHOD FOR DETERMINING DOPAMINE SYNTHESIS AND OUTPUT OF DOPAMINE METABOLITES FROM BRAIN IN AWAKE ANIMALSJournal of Neurochemistry, 1979
- CLONIDINE BLOCKS ACUTE OPIATE-WITHDRAWAL SYMPTOMSThe Lancet, 1978
- The determination of a brain arteriovenous difference for 3-methoxy-4-hydroxyphenethyleneglycol (MHPG)Brain Research, 1976
- Estimation of the contribution of peripheral and central noradrenergic neurones to urinary 3-methoxy-4-hydroxyphenylglycol in the ratNeuropharmacology, 1974
- The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugsNeuropharmacology, 1973
- On the physiological disposition and possible mechanism of the antihypertensive action of debrisoquinBiochemical Pharmacology, 1969
- The influence of debrisoquin on the accumulation and metabolism of biogenic amines by the human platelet, in vivo and in vitroClinical Pharmacology & Therapeutics, 1969
- Studies on debrisoquine sulphate.BMJ, 1966